AI
ALNY icon

Atria Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Atria Investments’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.27M Buy
9,874
+3,701
+60% +$1.26M 0.04% 514
2025
Q4 		$2.45M Buy
6,173
+979
+19% +$433K 0.03% 638
2025
Q3 		$2.37M Buy
5,194
+918
+21% +$374K 0.03% 659
2025
Q2 		$1.39M Buy
4,276
+72
+2% +$19.9K 0.02% 886
2025
Q1 		$1.14M Buy
4,204
+893
+27% +$229K 0.01% 946
2024
Q4 		$779K Buy
3,311
+166
+5% +$43.7K 0.01% 1118
2024
Q3 		$865K Buy
3,145
+1,387
+79% +$361K 0.01% 1049
2024
Q2 		$427K Buy
+1,758
New +$278K 0.01% 1383

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return